Ceftolozane/Tazobactam: a new option in the treatment of complicated gram-negative infections.

January 15, 2016 at 9:08 am

P T. 2014 Dec;39(12):825-32.

Sorbera M, Chung E, Ho CW, Marzella N.

Abstract

Ceftolozane/tazobactam: a new option in the treatment of complicated gram-negative infections.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264669/pdf/ptj3912825.pdf

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Metodos diagnosticos, Resistencia bacteriana, Sepsis. Tags: .

Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12). Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).


Calendar

January 2016
M T W T F S S
« Dec   Feb »
 123
45678910
11121314151617
18192021222324
25262728293031

Most Recent Posts


%d bloggers like this: